Campus Berlin Buch (CBB)

Details Associates

Name :

Campus Berlin Buch (CBB)

Address  :

ECRC Experimental and Clinical Research Center
Lindenberger Weg 80

Town  :


State  :


Country  :


Post Code:


Phone  :

49 30 450 50

Web URL  :

  • Oncologist

Total Number Of Beds : 5000

Featured Hospitals Listing
German Hospital Service
Destouchesstr. 1 Munchen Bayern (Germany)
Phone : 49 89 41610705
Email :
Website URL : Available


At the Campus BerlinBuch in northeast Berlin the Chariteacute Universitaumltsmedizin Berlin enjoys a partnership with the clinical and research institutions who specialize in basic research and comprehensive clinical care as well as with several biotechnology companies

For more than 100 years BerlinBuch has served as a key location for health care and research Between 1900 and 1920 hospitals with more than 5000 patient beds were constructed in BerlinBuch including the largest hospital in Europe at the time The clinical environment attracted scientific institutes and in 1930 the KaiserWilhelmInstitute for Brain Research moved to Buch Later the GDRs Academy of Sciences continued the biomedical research tradition here

Today the Campus BerlinBuch comprised of Specialized Clinics for Cancer and Cardiovascular Disease the Max Delbruumlck Center for Molecular Medicine MDC BerlinBuch the LeibnizInstitut fuumlr Molekulare Pharmakologie FMP as well as the biotechnology park with circa 50 companies is one of the largest biomedical centres in Germany In addition further hospitals and clinics call Buch home such as the Protestant Lung Clinic Berlin Evangelische Lungenklinik Berlin and the Rheuma Clinic BerlinBuch
Regular jogging increases life expectancy

Between 60 and 90 minutes of jogging per week at a slow or average pace delivers optimum benefits for longevity researchers in Germany found Peter Schnohr chief cardiologist of the Copenhagen City Heart Study at Bispebjerg University Hospital Copenhagen said in the jogging substudy the mortality of 1116 male joggers and 762 female joggers was co... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More